Blood vitamin D status and metabolic syndrome in the general adult population

A dose-response meta-analysis

Sang Yhun Ju, Hyun Suk Jeong, Do-Hoon Kim

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Context: Increasing evidence has suggested an association between blood vitamin D levels and metabolic syndrome. Objective: Our objective was to determine the relationship between blood vitamin D status and metabolic syndrome in the general adult population, using a dose-response meta-analysis. Data Source: We searched the PubMed, EMBASE, Web of Science, and Cochrane Library databases through July 2013 to identify relevant studies. Study Selection: Observational studies, reporting risk ratios with a 95% confidence interval (CI) for metabolic syndrome in ≥3 categories of blood 25-hydroxyvitamin D [25(OH)D] levels, were selected. Data Extraction: Data extraction was performed independently by 2 authors, and the quality of the studies was evaluated using the risk of bias assessment tool for nonrandomized studies. Data Synthesis: The pooled odds ratio of metabolic syndrome per 25 nmol/L increment in the serum/plasma 25(OH)D concentration was 0.87 (95% CI = 0.83-0.92, I2 = 85%), based on 16 "cross-sectional studies" and 1.00 (95% CI = 0.98-1.02, I2 = 0%) for 2 "cohort and nested casecontrol studies." The dose-response meta-analysis showed a generally linear, inverse relationship between 25(OH)D levels and metabolic syndrome in the cross-sectional studies (P for linear trend < .001). Conclusions: Blood vitamin D levels were associated with a risk of metabolic syndrome in crosssectional studies but not in longitudinal studies. Randomized, clinical trials will be necessary to address the issue of causality and to determine whether vitamin D supplementation is effective for the prevention of metabolic syndrome.

Original languageEnglish
Pages (from-to)1053-1063
Number of pages11
JournalJournal of Clinical Endocrinology and Metabolism
Volume99
Issue number3
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Vitamin D
Meta-Analysis
Blood
Population
Confidence Intervals
Cross-Sectional Studies
Odds Ratio
Library Science
Association reactions
Plasmas
Information Storage and Retrieval
PubMed
Causality
Observational Studies
Longitudinal Studies
Randomized Controlled Trials
Databases
Serum

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Blood vitamin D status and metabolic syndrome in the general adult population : A dose-response meta-analysis. / Ju, Sang Yhun; Jeong, Hyun Suk; Kim, Do-Hoon.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 99, No. 3, 01.01.2014, p. 1053-1063.

Research output: Contribution to journalArticle

@article{4c88a40a54f24c3db1b6af42285770e2,
title = "Blood vitamin D status and metabolic syndrome in the general adult population: A dose-response meta-analysis",
abstract = "Context: Increasing evidence has suggested an association between blood vitamin D levels and metabolic syndrome. Objective: Our objective was to determine the relationship between blood vitamin D status and metabolic syndrome in the general adult population, using a dose-response meta-analysis. Data Source: We searched the PubMed, EMBASE, Web of Science, and Cochrane Library databases through July 2013 to identify relevant studies. Study Selection: Observational studies, reporting risk ratios with a 95{\%} confidence interval (CI) for metabolic syndrome in ≥3 categories of blood 25-hydroxyvitamin D [25(OH)D] levels, were selected. Data Extraction: Data extraction was performed independently by 2 authors, and the quality of the studies was evaluated using the risk of bias assessment tool for nonrandomized studies. Data Synthesis: The pooled odds ratio of metabolic syndrome per 25 nmol/L increment in the serum/plasma 25(OH)D concentration was 0.87 (95{\%} CI = 0.83-0.92, I2 = 85{\%}), based on 16 {"}cross-sectional studies{"} and 1.00 (95{\%} CI = 0.98-1.02, I2 = 0{\%}) for 2 {"}cohort and nested casecontrol studies.{"} The dose-response meta-analysis showed a generally linear, inverse relationship between 25(OH)D levels and metabolic syndrome in the cross-sectional studies (P for linear trend < .001). Conclusions: Blood vitamin D levels were associated with a risk of metabolic syndrome in crosssectional studies but not in longitudinal studies. Randomized, clinical trials will be necessary to address the issue of causality and to determine whether vitamin D supplementation is effective for the prevention of metabolic syndrome.",
author = "Ju, {Sang Yhun} and Jeong, {Hyun Suk} and Do-Hoon Kim",
year = "2014",
month = "1",
day = "1",
doi = "10.1210/jc.2013-3577",
language = "English",
volume = "99",
pages = "1053--1063",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Blood vitamin D status and metabolic syndrome in the general adult population

T2 - A dose-response meta-analysis

AU - Ju, Sang Yhun

AU - Jeong, Hyun Suk

AU - Kim, Do-Hoon

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Context: Increasing evidence has suggested an association between blood vitamin D levels and metabolic syndrome. Objective: Our objective was to determine the relationship between blood vitamin D status and metabolic syndrome in the general adult population, using a dose-response meta-analysis. Data Source: We searched the PubMed, EMBASE, Web of Science, and Cochrane Library databases through July 2013 to identify relevant studies. Study Selection: Observational studies, reporting risk ratios with a 95% confidence interval (CI) for metabolic syndrome in ≥3 categories of blood 25-hydroxyvitamin D [25(OH)D] levels, were selected. Data Extraction: Data extraction was performed independently by 2 authors, and the quality of the studies was evaluated using the risk of bias assessment tool for nonrandomized studies. Data Synthesis: The pooled odds ratio of metabolic syndrome per 25 nmol/L increment in the serum/plasma 25(OH)D concentration was 0.87 (95% CI = 0.83-0.92, I2 = 85%), based on 16 "cross-sectional studies" and 1.00 (95% CI = 0.98-1.02, I2 = 0%) for 2 "cohort and nested casecontrol studies." The dose-response meta-analysis showed a generally linear, inverse relationship between 25(OH)D levels and metabolic syndrome in the cross-sectional studies (P for linear trend < .001). Conclusions: Blood vitamin D levels were associated with a risk of metabolic syndrome in crosssectional studies but not in longitudinal studies. Randomized, clinical trials will be necessary to address the issue of causality and to determine whether vitamin D supplementation is effective for the prevention of metabolic syndrome.

AB - Context: Increasing evidence has suggested an association between blood vitamin D levels and metabolic syndrome. Objective: Our objective was to determine the relationship between blood vitamin D status and metabolic syndrome in the general adult population, using a dose-response meta-analysis. Data Source: We searched the PubMed, EMBASE, Web of Science, and Cochrane Library databases through July 2013 to identify relevant studies. Study Selection: Observational studies, reporting risk ratios with a 95% confidence interval (CI) for metabolic syndrome in ≥3 categories of blood 25-hydroxyvitamin D [25(OH)D] levels, were selected. Data Extraction: Data extraction was performed independently by 2 authors, and the quality of the studies was evaluated using the risk of bias assessment tool for nonrandomized studies. Data Synthesis: The pooled odds ratio of metabolic syndrome per 25 nmol/L increment in the serum/plasma 25(OH)D concentration was 0.87 (95% CI = 0.83-0.92, I2 = 85%), based on 16 "cross-sectional studies" and 1.00 (95% CI = 0.98-1.02, I2 = 0%) for 2 "cohort and nested casecontrol studies." The dose-response meta-analysis showed a generally linear, inverse relationship between 25(OH)D levels and metabolic syndrome in the cross-sectional studies (P for linear trend < .001). Conclusions: Blood vitamin D levels were associated with a risk of metabolic syndrome in crosssectional studies but not in longitudinal studies. Randomized, clinical trials will be necessary to address the issue of causality and to determine whether vitamin D supplementation is effective for the prevention of metabolic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=84895785389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895785389&partnerID=8YFLogxK

U2 - 10.1210/jc.2013-3577

DO - 10.1210/jc.2013-3577

M3 - Article

VL - 99

SP - 1053

EP - 1063

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -